Non-Hodgkin lymphoma following temozolomide

Pediatric Blood and Cancer

Volumn 53, Issue 4, 2009, Pages 661-662

  Sharma, Atul ^a   Gupta, Deepak ^a   Mohanti, B K ^a   Thulkar, Sanjay ^a   Dwary, Amit ^a   Goyal, Shikha ^a   Muzumder, Sandeep ^a   Das, Prasenjit ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Glioblastoma multiforme; Non Hodgkin lymphoma; Second malignancy; Temozolomide

Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; KI 67 ANTIGEN; PREDNISONE; PROTEIN P53; TEMOZOLOMIDE; VINCRISTINE; ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE;

ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CERVICAL LYMPH NODE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; EDEMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FEVER; GENE MUTATION; GLIOBLASTOMA; HEADACHE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; NECROSIS; PRIORITY JOURNAL; TUMOR BIOPSY; VOMITING; WEIGHT REDUCTION; CHEMICALLY INDUCED DISORDER; NONHODGKIN LYMPHOMA; SECOND CANCER;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; LYMPHOMA, NON-HODGKIN; NEOPLASMS, SECOND PRIMARY;

EID: 69849104502     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22090     Document Type: Article

References (7)

1. Stevens MF, Hickman JA, Langdon SP, et al. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin- 4(3H)-one (CCRG 81045: M & B39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res 1987;47:5846-5852.
2. Stupp R, Mason WP, Van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolamide for glioblastoma. N Engl J Med 2005;352:987-996. (Pubitemid 40349501)
3. Noronha V, Berliner N, Ballen KK, et al. Treatment related myelodysplasia/AML in a patient with history of breast cancer and an oligidendroglioma treated with temozolamide: Case study and review of literature. Neuro Oncol 2006;8:280-283. (Pubitemid 46542652)
4. Su YW, Chang MC, Chiang MF, et al. Treatment related myelodysplastic syndrome after temozolamide for recurrent high grade glioma. J Neuro Oncol 2005;71:315-318.
5. Neyns B, Cordera S, Joosens E, et al. Non-Hodgkin's lymphoma in patients with glioma treated with temozolamide. J Clin Oncol 2008;26:4518-4519.
6. Radaelli F, Onida F, Rossi FG, et al. Second malignancies in essential thrombocythemia(ET): A retrospective analysis of 331 patients with long term follow up from single institution. Heamtology 2008;13:195-202.
7. Moser EC, Noordijk EM, van Leeuwen FE, et al. Risk of secondary cancer after treatment of aggressive non-Hodgkin's lymphoma: An EORTC cohort study. Hematologica 2006;91:1481-1488.